Literature DB >> 9280830

Further cases of valvular heart disease associated with fenfluramine-phentermine.

D J Graham, L Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9280830     DOI: 10.1056/NEJM199708283370911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 2.  Helping an obese patient make informed choices.

Authors:  C D Mulrow
Journal:  BMJ       Date:  1998-07-25

3.  Acute tryptophan depletion in accordance with body weight: influx of amino acids across the blood-brain barrier.

Authors:  V L S Dingerkus; T J Gaber; K Helmbold; S Bubenzer; A Eisert; C L Sánchez; F D Zepf
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

Review 4.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

Review 5.  Mitral Valve Pathology.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-05-23       Impact factor: 2.931

Review 6.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke.

Authors:  L E Derby; M W Myers; H Jick
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

Review 8.  Current concepts in the pharmacological management of obesity.

Authors:  P J Carek; L M Dickerson
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

9.  Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs.

Authors:  S Rajamani; C Studenik; R Lemmens-Gruber; P Heistracher
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 10.  The use of lorcaserin in the management of obesity: a critical appraisal.

Authors:  Bo Bai; Yu Wang
Journal:  Drug Des Devel Ther       Date:  2010-12-20       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.